Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JYHB2500300	硫酸拉罗替尼胶囊	larotrectinib sulfate	Capsule	Chemical Drugs	Supplementary Application	2025-06-04	Bayer AG	view
JYHB2500299	硫酸拉罗替尼胶囊	larotrectinib sulfate	Capsule	Chemical Drugs	Supplementary Application	2025-06-04	Bayer AG	view
JYHB2500117	硫酸拉罗替尼胶囊	larotrectinib sulfate	Capsule	Chemical Drugs	Supplementary Application	2025-03-08	Bayer AG;Penn Pharmaceutical Services Ltd	view
JYHB2500116	硫酸拉罗替尼胶囊	larotrectinib sulfate	Capsule	Chemical Drugs	Supplementary Application	2025-03-08	Bayer AG;Penn Pharmaceutical Services Ltd	view
JYHB2300660	硫酸拉罗替尼胶囊	larotrectinib sulfate	Capsule	Chemical Drugs	Supplementary Application	2023-11-17	Bayer AG;Penn Pharmaceutical Services Ltd	view
JYHB2300659	硫酸拉罗替尼胶囊	larotrectinib sulfate	Capsule	Chemical Drugs	Supplementary Application	2023-11-17	Bayer AG;Penn Pharmaceutical Services Ltd	view